文献速递神经MR

磁敏感加权成像上同侧突出丘脑纹状体静脉预测急性缺血性卒中静脉溶栓后不良预后

Ipsilateral Prominent Thalamostriate Vein on Susceptibility-Weighted Imaging Predicts Poor Outcome after Intravenous Thrombolysis in Acute Ischemic Stroke.
PubMed 文献 · AJNR Am J Neuroradiol · 2017-03-16

回顾性分析109例接受静脉溶栓的急性缺血性卒中患者,计算溶栓前SWI上丘脑纹状体静脉、隔静脉和大脑内静脉的信号差异比。仅丘脑纹状体静脉信号差异比>4.8%与3个月不良预后(mRS>2)独立相关(敏感度53.7%、特异度80.9%)。定义信号差异比≥5%为同侧突出丘脑纹状体静脉,该征象与不良预后(OR=3.66)和较低成功再灌注率(OR=0.35)相关。

要点

  • 溶栓前SWI丘脑纹状体静脉信号差异比>4.8%预测3个月不良预后,敏感度53.7%、特异度80.9%。
  • 同侧丘脑纹状体静脉信号差异比≥5%定义为同侧突出丘脑纹状体静脉。
  • 同侧突出丘脑纹状体静脉者不良预后OR=3.66(95%CI 1.25-10.68),成功再灌注OR=0.35(95%CI 0.13-0.92)。

核心结论

  • 溶栓前同侧突出丘脑纹状体静脉与溶栓后再灌注减少和不良预后相关;作者认为此类患者可能需要更积极的再灌注策略。

研究设计与样本

  • 回顾性分析109例连续急性缺血性卒中患者,均有溶栓前SWI并在6小时内接受静脉溶栓;计算丘脑纹状体静脉、隔静脉和大脑内静脉的信号差异比(同侧与对侧静脉信号强度的相对差异)。

关键影像表现/征象

  • 仅丘脑纹状体静脉信号差异比与不良预后显著相关(3个月改良Rankin量表评分>2,P=0.008);同侧突出丘脑纹状体静脉定义为信号差异比≥5%。

诊断标准与关键数值

  • 丘脑纹状体静脉信号差异比最佳阈值为同侧静脉相对低信号>4.8%,敏感度53.7%、特异度80.9%;信号差异比≥5%定义为同侧突出丘脑纹状体静脉。

临床应用与阅片要点

  • 阅片时可在溶栓前SWI上测量丘脑纹状体静脉同侧与对侧的信号差异比,≥5%提示同侧突出丘脑纹状体静脉,与不良预后和较低成功再灌注率(再灌注率≥70%,OR=0.35)相关;作者认为此类患者可能需要更积极的再灌注策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: The impact of deep cerebral veins on neurologic outcome after intravenous thrombolysis in patients with acute ischemic stroke is unclear. We investigated the relationship between the appearance of deep cerebral veins on susceptibility-weighted imaging and neurologic outcome in patients who underwent thrombolysis.

MATERIALS AND METHODS: We retrospectively analyzed 109 consecutive patients with acute ischemic stroke who had pretreatment SWI and received intravenous thrombolysis within 6 hours. We calculated the signal difference ratio (defined as the relative difference in signal intensity between the ipsilateral and contralateral veins) of the thalamostriate vein, septal vein, and internal cerebral vein on pretreatment SWI.

RESULTS: Only the signal difference ratio of the thalamostriate vein was significantly associated with poor outcome (3-month modified Rankin Scale score > 2, P = .008). The optimal threshold was relative hypointensity of the ipsilateral vein of >4.8% (sensitivity of 53.7% and specificity of 80.9%). We defined a signal difference ratio of the thalamostriate vein of ≥5% as an ipsilateral prominent thalamostriate vein. Patients with an ipsilateral prominent thalamostriate vein were more likely to have poor outcome (OR = 3.66; 95% CI, 1.25-10.68; P = .02) and a lower rate of successful reperfusion (reperfusion rate of ≥70%; OR = 0.35; 95% CI, 0.13-0.92; P = .03), compared with those without an ipsilateral prominent thalamostriate vein. However, patients with an ipsilateral prominent thalamostriate vein were still less likely to experience poor outcome when reperfusion was achieved compared with when reperfusion did not occur (80.0% versus 44.4%, P = .04).

CONCLUSIONS: A pretreatment ipsilateral prominent thalamostriate vein was associated with reduced reperfusion after thrombolysis and poor outcome. More intensive reperfusion approaches may be required for patients with an ipsilateral prominent thalamostriate vein.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Zhang X, Zhang S, Chen Q, et al. Ipsilateral Prominent Thalamostriate Vein on Susceptibility-Weighted Imaging Predicts Poor Outcome after Intravenous Thrombolysis in Acute Ischemic Stroke. AJNR Am J Neuroradiol. 2017. PMID: 28302608. doi:10.3174/ajnr.A5135

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。